Impact of Tumor Size on the Difficulty of Laparoscopic Major Hepatectomies: An International Multicenter Study.


Journal

Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 17 11 2022
accepted: 19 06 2023
medline: 20 9 2023
pubmed: 28 7 2023
entrez: 28 7 2023
Statut: ppublish

Résumé

Although tumor size (TS) is known to affect surgical outcomes in laparoscopic liver resection (LLR), its impact on laparoscopic major hepatectomy (L-MH) is not well studied. The objectives of this study were to investigate the impact of TS on the perioperative outcomes of L-MH and to elucidate the optimal TS cutoff for stratifying the difficulty of L-MH. This was a post-hoc analysis of 3008 patients who underwent L-MH at 48 international centers. A total 1396 patients met study criteria and were included. The impact of TS cutoffs was investigated by stratifying TS at each 10-mm interval. The optimal cutoffs were determined taking into consideration the number of endpoints which showed a statistically significant split around the cut-points of interest and the magnitude of relative risk after correction for multiple risk factors. We identified 2 optimal TS cutoffs, 50 mm and 100 mm, which segregated L-MH into 3 groups. An increasing TS across these 3 groups (≤ 50 mm, 51-100 mm, > 100 mm), was significantly associated with a higher open conversion rate (11.2%, 14.7%, 23.0%, P < 0.001), longer operating time (median, 340 min, 346 min, 365 min, P = 0.025), increased blood loss (median, 300 ml,  ml, 400 ml, P = 0.002) and higher rate of intraoperative blood transfusion (13.1%, 15.9%, 27.6%, P < 0.001). Postoperative outcomes such as overall morbidity, major morbidity, and length of stay were comparable across the three groups. Increasing TS was associated with poorer intraoperative but not postoperative outcomes after L-MH. We determined 2 TS cutoffs (50 mm and 10 mm) which could optimally stratify the surgical difficulty of L-MH.

Identifiants

pubmed: 37505351
doi: 10.1245/s10434-023-13863-z
pii: 10.1245/s10434-023-13863-z
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6628-6636

Subventions

Organisme : US National Cancer Institute MSKCC Core Grant
ID : P30 CA008747
Organisme : Research Project of Zhejiang Provincial Public Welfare Fund project in the Field of Social development
ID : LGF20H160028

Investigateurs

Mikel Prieto (M)
Celine De Meyere (C)
Juul Meurs (J)
Kit-Fai Lee (KF)
Diana Salimgereeva (D)
Ruslan Alikhanov (R)
Lip-Seng Lee (LS)
Jae Young Jang (JY)
Jaime Arthur Pirola Kruger (JAP)
Victor Lopez-Lopez (V)
Margarida Casellas I Robert (M)
Roberto Montalti (R)
Boram Lee (B)
Hao-Ping Wang (HP)
Mansour Saleh (M)
Simone Vani (S)
Francesco Ardito (F)
Ugo Giustizieri (U)
Davide Citterio (D)
Federico Mocchegiani (F)
Marco Colasanti (M)
Yoelimar Guzmán (Y)
Kevin P Labadie (KP)
Paolo Magistri (P)
Kohei Mishima (K)
Felix Krenzien (F)
Prashant Kadam (P)
Chung Ngai Tang (CN)
Jacob Ghotbi (J)
Åsmund Avdem Fretland (ÅA)
Mariano Giglio (M)
Alessandro Mazzotta (A)
Qu Liu (Q)
Shian Yu (S)

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023. Society of Surgical Oncology.

Références

Wakabayashi G, Cherqui D, Geller DA, Buell JF, Kaneko H, Han HS, et al. Recommendations for laparoscopic liver resection. A report from the Second International Consensus Conference held in Morioka. Ann Surg. 2015;261:619–29.
pubmed: 25742461
Ciria R, Cherqui D, Geller DA, Briceno J, Wakabayashi G. Comparative short-term benefits of laparoscopic liver resection: 9000 cases and climbing. Ann Surg. 2016;263:761–77.
doi: 10.1097/SLA.0000000000001413 pubmed: 26700223
Kasai M, Cipriani F, Gayet B, Aldrighetti L, Ratti F, Sarmiento JM, et al. Laparoscopic versus open major hepatectomy: a systematic review and meta-analysis of individual patient data. Surgery. 2018;163:985–95.
doi: 10.1016/j.surg.2018.01.020 pubmed: 29555197
Goh BKP, Lee SY, Teo JY, Kam JH, Jeyaraj PR, Chew PC, et al. Changing trends and outcomes associated with the adoption of minimally invasive hepatectomy: a contemporary single-institution experience with 400 consecutive resections. Surg Endosc. 2018;32(11):4658–65.
doi: 10.1007/s00464-018-6310-1 pubmed: 29967997
Ban D, Tanabe M, Ito H, Otsuka Y, Nitta H, Abe Y, et al. A novel difficulty scoring system for laparoscopic liver resection. J Hepato-Biliary-Pancreat Sci. 2014;21(10):745–53. https://doi.org/10.1002/jhbp.166 .
doi: 10.1002/jhbp.166
Wakabayshi G. What has changed after the Morioka consensus conference 2014 on laparoscopic liver resection? HepatoBiliary Surg Nutr. 2016;5(4):281–9.
doi: 10.21037/hbsn.2016.03.03
Halls MC, Beraldi G, Cipriani F, Barkhatov L, Lainas P, Harris S, et al. Development and validation of a difficulty score to predict intraoperative complications during laparoscopic liver resection. Br J Surg. 2018;105(9):1182–91.
doi: 10.1002/bjs.10821 pubmed: 29737513
Kawaguchi Y, Fuks D, Kokudo N, Gayet B. Difficulty of laparoscopic liver resection: proposal for a new classification. Ann Surg. 2018;267(1):13–7.
doi: 10.1097/SLA.0000000000002176 pubmed: 28187043
Hasegawa Y, Wakabayashi G, Nitta H, Takahara T, Katagiri H, Umemura A, et al. A novel model for prediction of pure laparoscopic liver resection surgical difficulty. Surg Endosc. 2017;31(12):5356–63.
doi: 10.1007/s00464-017-5616-8 pubmed: 28593408
Goh BKP, Prieto M, Syn N, Koh YX, Teo JY, Lee SY, et al. Validation and comparison of the Iwate, IMM, Southampton and Hasegawa difficulty scoring systems for primary laparoscopic hepatectomies. HPB (Oxford). 2021;23(5):770–6.
doi: 10.1016/j.hpb.2020.09.015 pubmed: 33023824
Linn YL, Wu AG, Han HS, Liu R, Chen KH, Fuks D, et al. Systematic review and meta-analysis of difficulty scoring systems for laparoscopic and robotic liver resections. J Hepatopancreat J Hepatobiliary Pancreat Sci. 2022;30:36–59.
doi: 10.1002/jhbp.1211 pubmed: 35780493
Kabir T, Syn N, Koh YX, Chung AY, Chan CY, Goh BKP. Impact of tumors size on the difficulty of minimally invasive liver resection. Eur J Surg Oncol. 2021;48:169–76.
doi: 10.1016/j.ejso.2021.08.019 pubmed: 34420824
Goh BK, Kabir T, Syn N. RE: new simple three-level liver resection classification without compromising the performance to predict surgical and postoperative outcomes. Eur J Surg Oncol. 2022;46:303–4.
doi: 10.1016/j.ejso.2021.11.129
Strasberg SM, Belghiti J, Clavien PA, Gadzijev E, Garden JO, Lau WY, et al. The Brisbane 2000 terminology of liver anatomy and resections. HPB. 2000;2(3):333–9.
doi: 10.1016/S1365-182X(17)30755-4
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.
doi: 10.1097/01.sla.0000133083.54934.ae pubmed: 15273542 pmcid: 1360123
Budczies J, Klauschen F, Sinn BV, Gyorffy B, Schmitt WD, Darb-Esfahani S, et al. Cutoff finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization. PloS One. 2012;7(12):e51862.
doi: 10.1371/journal.pone.0051862 pubmed: 23251644 pmcid: 3522617
Hothorn T, Hornik K, Zeileis A. Party: a laboratory for recursive partitioning. https://cran.r-project.org/web/packages/party/vignettes/party.pdf
Levi Sandri GB, Spoletini G, Vennarecci G, Francone E, Abu Hilal M, Ettorre GM. Laparoscopic liver resection for large HCC: short- and long-term outcomes in relation to tumor size. Surg Endosc. 2018;32(12):4772–9.
doi: 10.1007/s00464-018-6225-x pubmed: 29770883
Shelat VG, Cipriani F, Basseres T, Armstrong TH, Takhar AS, Pearce NW, et al. Pure laparoscopic liver resection for large malignant tumors: Does size matter? Ann Surg Oncol. 2015;22(4):1288–93. https://doi.org/10.1245/s10434-014-4107-6 .
doi: 10.1245/s10434-014-4107-6 pubmed: 25256130
Kabir T, Syn NL, Guo Y, Lim KI, Goh BKP. Laparoscopic liver resection for huge (> 10 cm) HCC: a coarsened exact-matched single-surgeon study. Surg Oncol. 2021;37:101569.
doi: 10.1016/j.suronc.2021.101569 pubmed: 33839442

Auteurs

Yutaro Kato (Y)

Department of Surgery, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

Atsushi Sugioka (A)

Department of Surgery, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

Masayuki Kojima (M)

Department of Surgery, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

Nicholas L Syn (NL)

Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Ministry of Health Holdings, Singapore, Singapore.

Wang Zhongkai (W)

Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital and National Cancer Centre Singapore, Singapore, Singapore.

Rong Liu (R)

Faculty of Hepatopancreatobiliary Surgery, The First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.

Federica Cipriani (F)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy.

Thomas Armstrong (T)

Department of Surgery, University Hospital Southampton, Southampton, UK.

Davit L Aghayan (DL)

The Intervention Centre and Department of HPB Surgery, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Tiing-Foong Siow (TF)

Division of General Surgery, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan.

Chetana Lim (C)

Department of Digestive, HBP and Liver Transplantation, Hopital Pitie-Salpetriere, Sorbonne Universite, Paris, France.

Olivier Scatton (O)

Department of Digestive, HBP and Liver Transplantation, Hopital Pitie-Salpetriere, Sorbonne Universite, Paris, France.

Paulo Herman (P)

Liver Surgery Unit, Department of Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil.

Fabricio Ferreira Coelho (FF)

Liver Surgery Unit, Department of Gastroenterology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil.

Marco V Marino (MV)

General Surgery Department, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.
Oncologic Surgery Department, P. Giaccone University Hospital, Palermo, Italy.

Vincenzo Mazzaferro (V)

HPB Surgery and Liver Transplantation, Fondazione IRCCS Istituto Nazionale Tumori di Milano and University of Milan, Milan, Italy.

Adrian K H Chiow (AKH)

Hepatopancreatobiliary Unit, Department of Surgery, Changi General Hospital, Singapore, Singapore.

Iswanto Sucandy (I)

Digestive Health Institute, AdventHealth Tampa, Tampa, FL, USA.

Arpad Ivanecz (A)

Department of Abdominal and General Surgery, University Medical Center Maribor, Maribor, Slovenia.

Sung Hoon Choi (SH)

Department of General Surgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.

Jae Hoon Lee (JH)

Division of Hepato-Biliary and Pancreatic Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Mikel Gastaca (M)

Hepatobiliary Surgery and Liver Transplantation Unit, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, University of the Basque Country, Bilbao, Spain.

Marco Vivarelli (M)

HPB Surgery and Transplantation Unit, United Hospital of Ancona, Department of Experimental and Clinical Medicine Polytechnic, University of Marche, Ancona, Italy.

Felice Giuliante (F)

Hepatobiliary Surgery Unit, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Catholic University of the Sacred Heart, Rome, Italy.

Bernardo Dalla Valle (B)

General and Hepatobiliary Surgery, Department of Surgery, GB Rossi Hospital, Dentistry, Gynecology and Pediatrics University of Verona, Verona, Italy.

Andrea Ruzzenente (A)

General and Hepatobiliary Surgery, Department of Surgery, GB Rossi Hospital, Dentistry, Gynecology and Pediatrics University of Verona, Verona, Italy.

Chee-Chien Yong (CC)

Department of Surgery, Chang Gung Memorial Hospital, Kaohsiung, Taiwan.

Constantino Fondevila (C)

General and Digestive Surgery, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
General and Digestive Surgery, Hospital Clinic, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain.

Mikhail Efanov (M)

Department of Hepato-Pancreato-Biliary Surgery, Moscow Clinical Scientific Center, Moscow, Russia.

Fabrizio Di Benedetto (F)

HPB Surgery and Liver Transplant Unit, University of Modena and Reggio Emilia, Modena, Italy.

Andrea Belli (A)

Division of Hepatopancreatobiliary Surgical Oncology, Department of Abdominal Oncology, National Cancer Center - IRCCS-G. Pascale, Naples, Italy.

James O Park (JO)

Department of Surgery, University of Washington Medical Center, Seattle, USA.

Fernando Rotellar (F)

HPB and Liver Transplant Unit, Department of General Surgery, Clinica Universidad de Navarra, Universidad de Navarra, Pamplona, Spain.
Institute of Health Research of Navarra (IdisNA), Pamplona, Spain.

Gi-Hong Choi (GH)

Division of Hepatopancreatobiliary Surgery, Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

Ricardo Robles-Campos (R)

Department of General, Visceral and Transplantation Surgery, Clinic and University Hospital Virgen de la Arrixaca, IMIB-ARRIXACA, El Palmar, Murcia, Spain.

Xiaoying Wang (X)

Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.

Robert P Sutcliffe (RP)

Department of Hepatopancreatobiliary and Liver Transplant Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Moritz Schmelzle (M)

Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin, Corporate Member of Freie Universität Berlin and Berlin Institute of Health, Berlin, Germany.

Johann Pratschke (J)

Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin, Corporate Member of Freie Universität Berlin and Berlin Institute of Health, Berlin, Germany.

Eric C H Lai (ECH)

Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong, SAR, China.

Charing C N Chong (CCN)

Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Ma Liu Shui, New Territories, Hong Kong, SAR, China.

Mathieu D'Hondt (M)

Department of Digestive and Hepatobiliary/Pancreatic Surgery, Groeninge Hospital, Kortrijk, Belgium.

Kazuteru Monden (K)

Department of Surgery, Fukuyama City Hospital, Hiroshima, Japan.

Santiago Lopez-Ben (S)

Hepatobiliary and Pancreatic Surgery Unit, Department of Surgery, Dr. Josep Trueta Hospital, IdIBGi, Girona, Spain.

T Peter Kingham (TP)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Fabio Forchino (F)

Department of General and Oncological Surgery, Mauriziano Hospital, Turin, Italy.

Alessandro Ferrero (A)

Department of General and Oncological Surgery, Mauriziano Hospital, Turin, Italy.

Giuseppe Maria Ettorre (GM)

Division of General Surgery and Liver Transplantation, San Camillo Forlanini Hospital, Rome, Italy.

Giovanni Battista Levi Sandri (GB)

Division of General Surgery and Liver Transplantation, San Camillo Forlanini Hospital, Rome, Italy.

Franco Pascual (F)

Department of Hepatobiliary Surgery, Assistance Publique Hopitaux de Paris, Centre Hepato-Biliaire, Paul-Brousse Hospital, Villejuif, France.

Daniel Cherqui (D)

Department of Hepatobiliary Surgery, Assistance Publique Hopitaux de Paris, Centre Hepato-Biliaire, Paul-Brousse Hospital, Villejuif, France.

Olivier Soubrane (O)

Department of Digestive, Oncologic and Metabolic Surgery, Institute Mutualiste Montsouris, Universite Paris Descartes, Paris, France.

Go Wakabayashi (G)

Division of HPB, Minimally Invasive and Robotic Surgery, Department of Clinical Medicine and Surgery, Federico II University Hospital Naples, Naples, Italy.

Roberto I Troisi (RI)

Division of HPB, Minimally Invasive and Robotic Surgery, Department of Clinical Medicine and Surgery, Federico II University Hospital Naples, Naples, Italy.

Tan-To Cheung (TT)

Department of Surgery, The School of Clinical Medicine, Queen Mary Hospital and HKU Shenzhen Hospital, The University of Hong Kong, Pokfulam, Hong Kong, SAR, China.

Zewei Chen (Z)

Department of Hepatobiliary Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.

Mengqiu Yin (M)

Department of Hepatobiliary Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.

Mizelle D'Silva (M)

Department of Surgery, Seoul National University Hospital Bundang, Seoul National University College of Medicine, Seoul, Korea.

Ho-Seong Han (HS)

Department of Surgery, Seoul National University Hospital Bundang, Seoul National University College of Medicine, Seoul, Korea.

Phan Phuoc Nghia (PP)

Department of Hepatopancreatobiliary Surgery, University Medical Center, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.

Tran Cong Duy Long (TCD)

Department of Hepatopancreatobiliary Surgery, University Medical Center, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.

Bjørn Edwin (B)

The Intervention Centre and Department of HPB Surgery, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

David Fuks (D)

Department of Digestive, Oncologic and Metabolic Surgery, Institute Mutualiste Montsouris, Universite Paris Descartes, Paris, France.

Kuo-Hsin Chen (KH)

Division of General Surgery, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan.

Mohammad Abu Hilal (M)

Department of Surgery, University Hospital Southampton, Southampton, UK.
Department of Surgery, Fondazione Poliambulanza, Brescia, Italy.

Luca Aldrighetti (L)

Hepatobiliary Surgery Division, IRCCS San Raffaele Hospital, Milan, Italy.

Brian K P Goh (BKP)

Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital and National Cancer Centre Singapore, Singapore, Singapore. bsgkp@hotmail.com.
Surgery Academic Clinical Programme, Duke-National University of Singapore Medical School, Singapore, Singapore. bsgkp@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH